T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope

被引:63
作者
Hombach, A
Heuser, C
Sircar, R
Tillmann, T
Diehl, V
Kruis, W
Pohl, C
Abken, H
机构
[1] UNIV COLOGNE,INNERE MED KLIN 1,D-50924 COLOGNE,GERMANY
[2] EVANGEL KRANKENHAUS KOLN,COLOGNE,GERMANY
关键词
D O I
10.1053/gast.1997.v113.pm9322511
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Chimeric receptors with specificity for defined tumor antigens are valuable tools for targeting cytolytic T cells specifically to tumor cells, The aim of this study, for the situation of gastrointestinal cancer, was to investigate the generation of a chimeric T cell receptor that specifically binds the tumor antigen TAG72 (CA72-4) and transmits a signal for cellular activation, Methods: A single-chain antibody (scFv) was derived from the monoclonal anti-TAG72 antibody B72.3 by phage display techniques (B72.3-scFv) and fused to the signaling unit of the Fc epsilon-RI receptor gamma chain, resulting in a chimeric signaling receptor, B72.3-scFv-gamma, Results: The B72.3-scFv and the chimeric B72.3-scFv-gamma receptor bound specifically to the TAG72 antigen, After transfection, T cells expressing the chimeric B72.3-scFv-gamma specifically recognized TAG72 positive cells, Cross-linking of the chimeric receptor with antigen resulted in interleukin 2 release and cytolytic activity against TAG72 positive tumor cells in vitro. Conclusions: T cells equipped with the chimeric anti-TAG72 receptor can be specifically activated to target and lyse TAG72 positive gastrointestinal tumor cells.
引用
收藏
页码:1163 / 1170
页数:8
相关论文
共 44 条
  • [21] PERFORIN EXPRESSION IN LYMPHOCYTES INFILTRATED TO HUMAN COLORECTAL-CANCER
    NAKANISHI, H
    MONDEN, T
    MORIMOTO, H
    KOBAYASHI, T
    SHIMANO, T
    MORI, T
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (02) : 239 - 242
  • [22] OHUCHI N, 1990, Journal of Tumor Marker Oncology, V5, P1
  • [23] FAMILY OF DISULFIDE-LINKED DIMERS CONTAINING THE ZETA-CHAIN AND ETA-CHAIN OF THE T-CELL RECEPTOR AND THE GAMMA-CHAIN OF FC-RECEPTORS
    ORLOFF, DG
    RA, C
    FRANK, SJ
    KLAUSNER, RD
    KINET, JP
    [J]. NATURE, 1990, 347 (6289) : 189 - 191
  • [24] DIFFERENT ROLES FOR THE FC-EPSILON-RI GAMMA-CHAIN AS A FUNCTION OF THE RECEPTOR CONTEXT
    PAOLINI, R
    RENARD, V
    VIVIER, E
    OCHIAI, K
    JOUVIN, MH
    MALISSEN, B
    KINET, JP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 247 - 255
  • [25] PARK JG, 1987, CANCER RES, V47, P6710
  • [26] AN ANALYSIS OF AUTOLOGOUS T-CELL ANTITUMOR RESPONSES IN COLON-CARCINOMA PATIENTS FOLLOWING ACTIVE SPECIFIC IMMUNIZATION (ASI)
    PATEL, BT
    LUTZ, MB
    SCHLAG, P
    SCHIRRMACHER, V
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (06) : 878 - 885
  • [27] CHIMERIC B72.3 MOUSE HUMAN (IGG1) ANTIBODY DIRECTS THE LYSIS OF TUMOR-CELLS BY LYMPHOKINE-ACTIVATED KILLER-CELLS
    PRIMUS, FJ
    PENDURTHI, TK
    HUTZELL, P
    KASHMIRI, S
    SLAVIN, DC
    CALLAHAN, R
    SCHLOM, J
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (06) : 349 - 357
  • [28] RAKESH KJ, 1989, J NATL CANCER I, V8, P570
  • [29] THE ROLE OF LYMPHOCYTE SUBSETS AND ADHESION MOLECULES IN T-CELL-DEPENDENT CYTOTOXICITY MEDIATED BY CD3 AND CD28 BISPECIFIC MONOCLONAL-ANTIBODIES
    RENNER, C
    JUNG, WF
    SAHIN, U
    VANLIER, R
    PFREUNDSCHUH, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (07) : 2027 - 2033
  • [30] TUMOR-THERAPY BY IMMUNE RECRUITMENT WITH BISPECIFIC ANTIBODIES
    RENNER, C
    PFREUNDSCHUH, M
    [J]. IMMUNOLOGICAL REVIEWS, 1995, 145 : 179 - 209